MedPath

Pulsatile Cupping in Low Back Pain

Not Applicable
Completed
Conditions
Chronic Low Back Pain
Interventions
Device: Minimal Cupping
Device: Pulsatile Cupping
Registration Number
NCT02090686
Lead Sponsor
Charite University, Berlin, Germany
Brief Summary

The purpose of this study is to determine whether pulsatile cupping with a cupping device is effective in the treatment of patients with chronic low back pain compared to no cupping or to minimal cupping.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
110
Inclusion Criteria
  • Male and female, 18-65 years
  • Chronic low back pain (disease duration > 3 months)
  • Pain intensity on visual analogue scale at inclusion > 40 mm (0-100 mm scale)
  • Only pharmacological treatment with NSAID or no treatment in the last 4 weeks
  • Undersigned informed consent form
Exclusion Criteria
  • Use of anticoagulants (Phenprocoumon, Heparin)
  • Coagulopathy
  • Cupping in the last 6 weeks
  • Other CAM therapies in the last 12 weeks (e.g. acupuncture)
  • Physical therapy in the last 12 weeks (e.g. massage, osteopathy)
  • participation in another study in the last 3 months
  • Paracetamol allergy or intolerance
  • Pathological neurological symptoms such as muscular paralysis or paraesthesia due to spinal disc herniation or other causes
  • Known renal and / or hepatic diseases
  • Intake of central nervous system-acting analgesics in the last 6 weeks
  • Applying for early retirement due to low back pain
  • Severe disease that does not allow participation
  • No undersigned informed consent form

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Minimal CuppingMinimal Cupping-
Pulsatile CuppingPulsatile Cupping-
Primary Outcome Measures
NameTimeMethod
Intensity of pain on visual analogues scale4 weeks
Secondary Outcome Measures
NameTimeMethod
Intensity of pain on visual analogue scale12 weeks
Back function - FFbH-R-Questionnaire4 weeks, 12 weeks
Quality of Life - SF 364 weeks, 12 weeks
Assessment of perceived effect on Likert Scale4 weeks, 12 weeks
Intake of paracetamol4 weeks
Adverse eventsweek 1- 12

Trial Locations

Locations (1)

Charité Universitätsmedizin Berlin

🇩🇪

Berlin, Germany

© Copyright 2025. All Rights Reserved by MedPath